Suche
Mein Konto
New weight loss drug Wegovy: One year after its introduction - trends, experiences and risks
Find out how successful the weight loss injection is for weight loss and what side effects can occur. Comprehensive overview in the article.
New weight loss drug Wegovy: One year after its introduction - trends, experiences and risks
New option for weight loss: The focus is on the weight loss syringe
The introduction of “Wegovy” has caused quite a stir in recent years. The prescription drug promises to help people lose weight by reducing appetite and increasing satiety. Since its approval for Germany in 2023, “Wegovy” has been used by many people to control their weight.
The active ingredient semaglutide, known under the trade name “Ozempic,” was already in use as a diabetes medication before it was approved for the treatment of obesity. This active ingredient mimics the action of the gut hormone GLP-1, which causes the body to eat less and feel full.
However, therapy with “Wegovy” can cause side effects such as nausea, gastrointestinal complaints and even inflammation. Therefore, it is recommended to take the drug under medical supervision to minimize possible risks.
It is important to emphasize that the weight loss injection is not a panacea and should always be used in conjunction with a balanced diet and regular exercise. Permanent lifestyle changes are crucial for long-term weight loss success.
An interesting aspect is that in addition to “Wegovy”, other providers have also brought weight loss injections onto the market. The US pharmaceutical company Eli Lilly sells the “Mounjaro” weight loss syringe with the active ingredient tirzepatide. Studies have shown that it may be able to achieve greater weight loss than semaglutide.
It is crucial that weight loss injections be used with caution and under medical supervision. The focus should always be on long-term and healthy weight loss in order to achieve long-term success.